The individual vasodilatory activity of ethyl caffeate and its potential effect as an angiotensin-converting enzyme inhibitor, in vitro, may suggest a mechanism for this compound to reduce hypertension [59,60]. This evidence concerns the gene ACE and hypertensive disorder.